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DNA Oligonucleotide, a short piece of DNA, is one of the most commonly used materials 
in biomolecular applications. Nowadays, most oligonucleotides are synthesized in 
commercialized oligonucleotide synthesizers. Due to the complexity of the synthesis 
process, these synthesizers are bulky in size. Recently, there is an emerging need of on-
site applications of oligonucleotides, such as in civil defense to immediately detect 
biological attacks. However, due to the size limitation of the available oligonucleotide 
synthesizers, only pre-made oligonucleotides with certain sequence can be brought to the 
field. It is practically impossible to get oligonucleotide of any sequence on demand in the 
field. In this thesis, a solution is offered by proposing and building a portable 
oligonucleotide synthesizer based on microfluidic technology. 
 
Firstly, a microfluidic chip with integrated microvalves is developed. The microvalves 
have zero dead-volume characteristic that is attributed to the design of zigzag shaped 
main channel and special position of each microvalve. This design removes the 
connecting channels between the microvalve and the main channel that are usually found 
in traditional designs. Therefore, reagents cannot be trapped within the microfluidic 
device and cross contamination can be effectively minimized. The zero dead-volume 
characteristic is proven by detection of trace amount of DNA template molecules trapped 
in the device. This contamination free characteristic is extremely important for 
applications, such as DNA oligonucleotide synthesis, in which cross contamination is 
 vii 
 
critical issue and can lead to failure of the synthesis.  
 
Secondly, a portable oligonucleotide synthesizer based on the developed zero dead-
volume microchip is built. The portable synthesizer has the ability to synthesize 
oligonucleotide as either primer or probe. The sequence and biological functionality of 
the synthesized oligonucleotides are proven by polyacrylamide gel electrophoresis, PCR 
and DNA hybridization experiment. The portable synthesizer has the ability to synthesize 
oligonucleotide of any sequence on demand. To the best of our knowledge, this is the first 
reported portable oligonucleotide synthesizer.  
 
To further improve the function of the portable system and realize generic DNA bioassay 
within it, a DNA hybridization and fluorescence detection unit is presented and integrated 
into the portable synthesizer. The fully integrated system, a portable generic DNA 
hybridization bioassay system, is successfully used to distinguish different bacteria 
strains based on in situ DNA oligonucleotide synthesis, hybridization and fluorescence 
detection. As far as we know, this is also the first portable generic DNA bioassay system 
reported. As the system has the potential to detect DNA target of any sequence in the field, 
we envisage that the system could help to enable fast responses to emerging bio-threats 
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A DNA oligonucleotide is a single stranded, short fragment of DNA. The length of DNA 
oligonucleotide usually ranges from a few bases to 50 bases. However, oligonucleotides 
with length around 20 bases are more widely used in biomolecular applications and 
studies. Applications for DNA oligonucleotides are widely found in biological studies 
such as polymerase chain reaction (PCR) which uses DNA oligonucleotide as a primer to 
initiate the PCR reaction [1], DNA microarray which uses DNA oligonucleotide as a 
probe for DNA hybridization [2], or gene synthesis which uses DNA oligonucleotide as 
the basic building blocks to form the target gene [3]. To obtain oligonucleotide with 
desired sequence, chemical synthesis of oligonucleotide by polymerizing individual 
nucleotide precursors is commonly used. 
 
1.1.1 DNA oligonucleotide 
It has been more than 50 years since the first dimer oligonucleotide was chemically 
synthesized [4]. Since then, the research on oligonucleotide synthesis chemistry has been 
extensively conducted due to numerous applications for DNA oligonucleotides. 
Nowadays, the phosphoramidite method has become the ‘golden standard’ approach for 
oligonucleotide synthesis [5]. The essence of this method is polymerizing nucleoside 
phosphoramidite one by one according to the required sequence. Several different 




phosphoramidite is added onto the growing chain in one cycle. The synthesis of an 
oligonucleotide with specific length and sequence requires the repetition of this synthesis 
cycle for a number of times. In Chapter 2, various oligonucleotide synthesis chemistries 
and recent improvement will be reviewed. 
 
Nowadays, the oligonucleotide synthesis process has been fully automated. Most 
oligonucleotides are synthesized in commercialized oligonucleotide synthesizers [6, 7]. 
However, due to the complexity of the synthesis process, these synthesizers are bulky in 
size. Recently, there is an emerging need of “in the field applications” for 
oligonucleotides, such as in civil defense to immediately detect biological attacks. 
However, due to the size limitation of the available oligonucleotide synthesizers, only 
pre-synthesized oligonucleotides with certain sequence can be brought to the field. It is 
practically impossible to get any sequence on demand in the field. This is because, for 
example, for a 20-mer oligonucleotide, there are totally 420 (=1.1× 1012) possible 
sequences, the cost for synthesizing and storing all the possible sequences is tremendous 
and increases exponentially with the increase in the length of the oligonucleotide. 
Therefore, only selected oligonucleotides can be prepared and brought in the field. As a 
consequence, no immediate detection and response to artificially manipulated or naturally 
mutated agents harmful to human in the field is possible. Thus, it is absolutely necessary 
to develop an oligonucleotide synthesizer in a portable format in order to obtain 




1.1.2 Microfluidic device 
Microfluidic device or Lab-on-a-chip has gained a lot of attention and applications in the 
past two decades. Its broad applications in biological and chemical studies such as DNA 
analysis [8], cell separation [9], cell culture [10], and material synthesis [11] make it a 
dynamic research area. The decrease of fluidic devices in dimension to micrometer scale 
leads to the dramatic reduction of the volume to microliter or nanoliter. The small volume 
of microfluidic devices reduces the consumption of chemicals and production of waste, 
which is environment friendly and cost saving. Furthermore, many reactions can be 
carried out simultaneously on a single chip, which increases the throughput [12]. The use 
of silicon-based polymers in biological studies such as poly(dimethylsiloxane) (PDMS) 
also makes the fabrication process of microfluidic device much easier and cheaper 
compared to the use of glass or silicon.  
 
Complicated systems based on microfluidic technologies have been reported [8, 12]. In 
these microfluidic systems, often microvalves are an important fundamental element, 
which implements the fluids control and manipulation in such devices. By integrating a 
number of valves in one microfluidic chip, multiple liquid reagents can be controlled in 
sequential or parallel manner as needed. Therefore, applications which require adding a 
number of different reagents in a certain sequence can be accomplished within 
microfluidic system. In chapter 2, various microvalves based on different actuation 




1.1.3 Combine oligonucleotide synthesis with microfluidic technologies 
As described, DNA oligonucleotide synthesis is such an application in which a number of 
reagents are involved. These reagents need to be added into the reactor chamber in a 
sequential manner for a series of reactions to take place. As microfluidic device has the 
ability to control and manipulate a number of fluids with the aid of microvalve 
technologies, combination of microfluidic technologies and DNA oligonucleotide 
synthesis chemistry should provide an easy and efficient way to synthesize DNA 
oligonucleotide. The microfluidic system can be then packed into a portable format to 
form a portable oligonucleotide synthesizer, which can be used for in the field 
applications. 
 
1.2 Scope and specific aims of study 
As the project is funded by Ministry of Defence of Singapore (MOD), the overall aim of 
the research is to develop a portable DNA oligonucleotide synthesizer for MOD for their 
in the field applications. The portable synthesizer should have the ability to synthesize 
DNA oligonucleotide of any sequence on demand and the synthesized oligonucleotide 
can be used as either primer or probe. Furthermore, the function of the portable system 
can be extended to conduct DNA hybridization based bioassay. These aims will be 




1. Develop a microvalves integrated microfluidic device which can control the flow of a 
number of reagents, the microfluidic device should minimize cross contamination 
among reagents within the device; 
2. Integrate the microfluidic device with the electronic and pneumatic controlling units, 
and pack them into a portable format to form the portable oligonucleotide synthesizer; 
3. Synthesize both DNA oligonucleotide primers and probes within the portable 
synthesizer; 
4. Design a hybridization and fluorescence detection unit and integrate it into the 
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2.1 DNA oligonucleotide synthesis 
DNA oligonucleotides are one of the most widely used materials in biomolecular 
applications and studies. Till now, almost all oligonucleotides used in those applications 
are chemically synthesized. However, researchers spent more than 25 years to find the 
satisfactory method to synthesize oligonucleotide. As the development of the computer 
technology and process automation, oligonucleotide synthesis has been fully automated 
and is carried out in commercialized oligonucleotide synthesizers. In this section, 
different oligonucleotide synthesis approaches will be reviewed first, followed by recent 
advances in solid phase synthesis and oligonucleotide synthesizer design. 
 
2.1.1 Synthesis chemistry 
It has been more than 50 years since the first synthesis of a dithymidine dinucleotide was 
reported by Michelson and Todd in 1955 [4]. Since then, extensive research has been 
conducted on the chemistry of oligonucleotide synthesis due to numerous applications of 
DNA oligonucleotides [2, 13-15]. Different approaches have been invented, including 
phosphodiester approach, phosphotriester approach, H-phosphonate approach and 
phosphoramidite approach. Among these methods, phosphoramidite approach has 
become the standard method and has been dominantly used in the past 20 years. However, 
it is necessary to understand all these methods and their respective contribution to the 
development of the oligonucleotide synthesis chemistry and inherent problems. Table 2-1 
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shows a brief summary of all these approaches and they will be reviewed in more details 
in the following. 
 
Table 2-1 Reaction scheme of different oligonucleotide synthesis approaches, their 
inherent problems and their contributions to the development of oligonucleotide synthesis 
chemistry 
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2.1.1.1 Phosphodiester approach 
In the second half of 1950s, Khorana and his co-workers developed the phosphodiester 
approach [16-18]. In the phosphodiester approach, phosphomonoester and the formed 
internucleotide phosphodiester are not protected during the coupling reaction, leading to 
the problem that oligonucleotides could branch at the internucleotide phosphate. 
Therefore, tedious purification is required. Due to these reasons, the phosphodiester 
approach was not in use since the 1970s. However, the use of dimethoxytrityl (DMT) as 5’ 
hydroxyl protecting group [19] and benzoyl and isobutyryl as base protecting group [20] 
are very important improvement. These protecting groups are still used in modern 
oligonucleotide synthesis (see phosphoramidite approach below). Another contribution 
that Khorana has made is the elucidation of genetic code by using this approach to 
synthesize short oligomers [21, 22]. 
 
2.1.1.2 Phosphotriester approach 
In the 1960s, phosphotriester approach was reinvestigated after first reported in 1955 by 
Michelson and Todd [4]. Its key difference from the phosphodiester approach is that the 
internucleotide phosphate is protected. Therefore, oligonucleotides could not branch at 
the internucleotide phosphate. A few protecting groups have been used for protecting the 
internucleotide phosphate, including 2-cyanoethyl group [23, 24]. Nowadays this group is 
still used in phosphoramidite approach (see below). The problem with this method is that 
Chapter 2 Literature Review 
11 
 
the coupling efficiency is relatively low, which therefore limits its use in synthesizing 
only short oligonucleotide [5]. However, the phosphotriester approach was the first 
method used in solid phase synthesis of oligonucleotide [23]. Thereafter, massive 
research in this area was initiated and automatic synthesis of oligonucleotide is made 
possible due to the success of solid phase synthesis.  Nowadays, most of the synthetic 
oligonucleotides, if not all, are synthesized by the solid phase approach. 
 
2.1.1.3 H-phosphonate approach 
Although first reported by Hall and co-workers in the 1950s [25], this method gained 
more attention thirty years later since it was applied to solid phase synthesis of 
oligonucleotide [26, 27]. In H-phosphonate approach, only one oxidation reaction is 
carried out to convert all the phosphonate diesters to the desired phosphodiesters at the 
end of the synthesis (different from phosphoramidite method that oxidation is carried out 
in each cycle, see below). The advantage of this method is that only two steps are 
involved in one synthesis cycle and oligonucleotide analogues can be easily obtained 
during the final oxidation by using different nucleophiles other than water [28, 29]. 
However, undesired side reaction during coupling and incomplete oxidation in the final 
step may lower the final yield of the synthesis. Therefore it is generally accepted that 
phosphoramidite approach is superior to H-phosphonate approach in terms of synthesis 
efficiency. 
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2.1.1.4 Phosphoramidite approach 
In the 1970s, phosphite triester approach, a revolutionary development in oligonucleotide 
synthesis chemistry, was reported [30]. This method was further developed to 
phosphoramidite approach a few years later by the introduction of nucleoside 
phosphoramidites by Beaucage and Caruthers in 1981 [31]. In this approach, the 
phosphite triester linkage [P(III)] is formed first during the coupling reaction and then 
oxidized to the desired phosphate triester linkage [P(V)]. This is because that P(III) is 
much more reactive than P(V) and therefore more efficient in the formation of 
internucleoside linkage [30]. Nowadays, the phosphoramidite approach has become the 
‘standard’ method and is dominantly used for oligonucleotide synthesis due to its high 
coupling yield (98%) [32]. Almost all automated synthesizers are specially designed for 
using phosphoramidite approach. Figure 2-1 shows the chemical structure of 
deoxyribonucleotide phosphoramidites which are the basic building blocks used in 
phosphoramidite approach. The protecting groups for protection of various functional 
groups during oligonucleotide synthesis are labeled in different colors. 





2.1.2 Solid phase synthesis 
Since first reported by Letsinger and Mahadevan in 1965 [23], enormous research was 
carried out on synthesizing oligonucleotide on solid support. In the past 20 years, almost 































































Figure 2-1 Chemical structures of deoxyribonucleotide phosphoramidites. The 
protecting groups are labeled in different colors: Red color: acid-labile DMT group to 
protect 5’-OH. Blue color: 2-cyanoethyl group to protect phosphite. Green color: 
isobutyryl or benzoyl group to protect exocyclic amino group. 
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of oligonucleotides, one nucleotide is added onto a support-bonded oligonucleotide at a 
time till the desired sequence is obtained. Phosphoramidite approach is the most widely 
used method for solid phase synthesis of oligonucleotide. In solid phase synthesis by 
phosphoramidite approach, a number of reactions forming a synthesis cycle are required 
to extend one nucleotide. These reactions include detritylation, coupling, oxidation, and 
capping, Excess reagents are usually added in each reaction to achieve higher synthesis 
yield and then washed off from the solid support after the reaction is completed [5]. A 
point worth noting is that the synthesis direction is from 3’ end to 5’ end, which is 
different from the direction of chain extension in natural DNA replication or PCR (5’ end 
to 3’ end). The solid phase synthesis technique is a rapid and efficient approach as excess 
reagents can be easily removed and thus no tedious and time-consuming purification is 
needed after each step. A practical importance of the success of solid phase synthesis is 
that it makes the automation of oligonucleotide synthesis become possible. Figure 2-2 
shows the reaction scheme of solid phase synthesis of oligonucleotide by using the 
phosphoramidite approach. 
 





2.1.2.1 Solid supports for oligonucleotide synthesis 
Various materials have been used as the solid support materials in oligonucleotide 
synthesis, such as silica gel, controlled-pore glass (CPG) and polystyrene [33-35]. Among 
these materials, CPG [34, 36] is still the most widely used support material nowadays. 
The pore size of CPG ranges from below 10 nm to several hundred nm. The nucleoside 
Figure 2-2 Scheme of solid phase oligonucleotide synthesis. Four reactions are involved
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loading decreases with increasing pore size, as the surface area on the CPG decreases 
with increasing pore size. However, longer oligonucleotide can be synthesized with larger 
pore size due to retaining of high coupling yield when growing strand became longer [37]. 
 
The commercialized CPG usually has the first nucleotide attached on the support (see 
Figure 2-2 ‘start’). The linkage between CPG and the first base is cleavable [38, 39]. 
Upon completion of the synthesis, the linkage is cleaved and the oligonucleotide is 
released from the CPG. The synthesized oligonucleotide bears 3’ end hydroxyl group, 
which is important for oligonucleotide primer to initiate PCR. There are four basic CPG 
(A, T, G, or C) available to start the synthesis and one must choose the CPG with the 
correct first base according to the 3’ end base of the required sequence (because synthesis 
direction was from 3’ end to 5’ end). This undoubtedly causes trouble and increases 
possibility of using the wrong CPG. Later on, universal linker chemistry was reported by 
various researchers [40-42]. The CPG with universal linker (universal CPG) does not 
have the first nucleotide attached on it. Therefore, the same solid support can be used 
regardless of the sequence to be synthesized, which is more convenient and reduces 
human error possibility. The universal CPG has the similar efficiency for oligonucleotide 
synthesis and no modification of synthesis chemistry is needed for using them on 
commercial oligonucleotide synthesizer. 
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2.1.2.2 Oligonucleotide synthesizer 
Oligonucleotide synthesis has been fully automated through the development of 
oligonucleotide synthesizers. In solid phase synthesis of oligonucleotides, a number of 
reagents are added and removed from the solid support in a sequential manner. Therefore, 
a valve system which controls the flow of different reagents is the most important part of 
an oligonucleotide synthesizer. A column with solid support packed within it is used as 
the synthesis reactor. However, the number of oligonucleotide that can be synthesized in 
parallel is limited.  
 
Later on, due to the high demand for oligonucleotides in genome-wide studies [43, 44], 
high throughput oligonucleotide synthesizers were developed. In the high throughput 
synthesizer, 96- and 384-well microplates were both successfully used as the synthesis 
reactor [7, 45]. A system consisting of four 384-well microplates has also been developed 
to further increase the throughput and has the ability to produce 1536 oligonucleotide at 
the same time [7]. However, for such highly parallel synthesis, well-to-well quality 
variation of the synthesized oligonucleotides remains a concern. Due to the high 
productivity and complexity of system design, all of these synthesizers are bulky in size. 
Currently, there are some research conducted on applying microfluidic technology on 
oligonucleotide synthesis, this will be reviewed later. 
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2.1.2.3 In situ oligonucleotide synthesis 
In situ oligonucleotide synthesis emerged through the development of DNA microarray 
technology. In situ oligonucleotide synthesis has the following advantages. Firstly, 
oligonucleotide synthesized on the substrate can be directly used for DNA hybridization; 
therefore, no immobilization of pre-synthesized oligonucleotide is required. Secondly, a 
large number of different sequences can be synthesized simultaneously at high surface 
density.  
 
Several techniques have been used in in situ synthesis of oligonucleotides, including ink-
jet printing [46, 47], micro-contact printing [48], and photolithography [49, 50]. Ink-jet 
printing technology has been successfully applied in fabricating microarray [46]. 
Phosphoramidites were delivered to dedicated location on a glass surface by the ink-jet 
printing process. An array of 23,965 oligonucleotides representing human genes was 
obtained on an area of 25 × 75 mm2 with 100 µm in diameter per spot. However, the 
coupling efficiency was estimated to be 94% to 98%, slightly lower than that of 
conventional oligonucleotide synthesis. 
 
Xiao and co-workers used PDMS micro-contact printing technology to synthesize 
oligonucleotide microarrays [48]. The synthesized oligonucleotide spots had a feature 
size of 90 µm in diameter and 2500 probes were produced in an area of 1 cm2. As many 
as 168 different microstamps were made for fabricating the 20-mer oligonucleotide array. 
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Extra attention must be paid on alignment of the microstamps and the substrate during the 
contact printing process to guarantee the quality of the synthesized oligonucleotides. The 
solvent compatibility of PDMS with oligonucleotide synthesis reagent was not mentioned 
in this study. 
 
In photolithography approach, the 3’ end hydroxyl is deprotected by light instead of acid 
as in the phosphoramidite approach. Therefore, a photo-labile protecting group replaced 
the traditional acid-labile DMT group. Photomasks [49] or micromirror array [50] were 
used to selectively produce the 3’ end hydroxyl at specific location. The synthesized 
oligonucleotide spot had a feature size smaller than 25 µm in diameter. The 
commercialized Affymetrix® DNA microarray chip is fabricated by this approach. 
However, the limitation of this method is that the synthesis efficiency is lower than that 
of traditional phosphoramidite chemistry, excluding its use in synthesizing longer 
sequences.  
 
To solve the lower synthesis efficiency problem, Gao and co-workers invented the 
photogenerated acid (PGA) approach [51, 52]. In this method, standard phosphoramidite 
chemistry, i.e., the acid-labile DMT protecting group, is used. The acid to remove the 
DMT group is generated by illumination of an acid precursor at selected reaction 
chambers. The generated acid then selectively removes the DMT group at specific 
chambers. The synthesis must be carried out in a microfluidic device with thousands of 
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micro chambers integrated instead of on flat substrate surface. When removing the DMT 
group, acid diffusion among different reaction chambers must be prevented, otherwise, 
the reaction will occur at wrong reaction chambers, leading to undesired oligonucleotide 
sequences. 
 
2.2 Microfluidic valve 
With the development and aid of microfabrication and micromachining technologies, 
microfluidic systems found applications in biological studies and material synthesis [10, 
53, 54]. The microfluidic valve is an important component in microfluidic devices. With 
microvalves integrated into the microfluidic system, it is possible to manipulate and 
control fluid flow within microfluidic devices. In the following sections, the microfluidic 
valve technology will be reviewed and the focus is on two types of pneumatically 
actuated microvalves, which are widely used in microfluidic biological systems. 
 
2.2.1 Passive and active microvalves 
Microvalves can be categorized into two main classes: passive valves and active valves. 
Passive valves, or check valves, only open to forward pressure [55-59]. This kind of 
valves has diode-like characteristics. The advantage of passive valves is that their design 
is relatively simple. However, its main disadvantage is that a leakage flow exists even 
under low pressure. This disadvantage excluded the use of such valves in applications 
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where leakage or cross contamination between reagents is a critical issue and must be 
avoided.  
 
Unlike passive valves, active valves can be operated by external means. Therefore, the 
valves behavior is not dependent on direction the fluid flow. It is generally accepted that 
active microvalves can be categorized into three subgroups according to their actuation 
means [60]: mechanical active microvalves, non-mechanical active microvalves and 
external active microvalves.  
 
For mechanical active microvalves, the movable membranes are coupled to mechanical 
moving parts which can be actuated by different methods such as magnetic, electric, 
piezoelectric or thermal means. In contrast, for non-mechanical microvalves, the movable 
membranes are actuated by means other than mechanical, e.g., electrochemical reaction 
or phase-change materials. For external active microvalves, they are usually actuated by 
external systems such as pneumatic pressure (more details in section 2.2.2). A brief list of 
the categorization of active microvalves and their respective operation time are 
summarized in Table 2-2. 
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Table 2-2 Categorization of active microvalves 
Category Actuation Method Mechanism Valving Time References 
Mechanical 
Magnetic Magnetic force 10 ms [61-64] 
Electric Electrostatic force ---- [65, 66] 
Piezo-
electric 







bimetallic 0.2 s  
 
thermopneumatic  
> 5 s 










> 1 min [73, 74] 
Phase 
change 
Phase change of 
hydrogel, sol-gel, 
or paraffin due to 
temperature, pH, or 
light 
> 2 s 
Hydrogel [75-77], 
Sol-gel[78], 




< 5 ms [81-85] 
 
2.2.2 Pneumatically actuated microvalves  
Pneumatically actuated microvalves are suitable for biological and chemical applications.  
This is due to the reasons that pneumatically actuated microvalves have the advantage of 
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fast actuation, ease of large-scale integration, no leakage flow and ease of fabrication. 
Two types of pneumatically actuated microvalves were previously reported [81, 85], they 
are  the pneumatic diaphragm microvalve and the pneumatic in-line microvalve.  
 
2.2.2.1 Pneumatic diaphragm microvalve 
The pneumatically actuated diaphragm microvalve was first reported by Vieider and co-
workers in 1995 [85]. This microvalve has a three-layer structure. In this design, a 
deflectable thin membrane is sandwiched in between a fluidic layer and a pneumatic layer. 
The microfluidic channel (on fluidic layer) is interrupted by a valve seat. The working 
principle of this type of microvalve is shown in Figure 2-3. The thin membrane is pressed 
against the valve seat if a positive pressure (relative to atmospheric pressure) is applied 
on the membrane through the pneumatic channel. Under positive pressure, the valve is 
closed and liquid is stopped behind the valve seat. On the other hand, if a negative 
pressure is applied, the membrane is deflected away from the valve seat and a connecting 
channel is formed in between. Under negative pressure, the valve is opened and liquid 
can flow over the valve seat.  




Figure 2-3 Schematic illustrating the working principle of the pneumatically actuated 
diaphragm microvalve. (a) The microvalve is closed when positive pressure is applied 
through the pneumatic port. (b) The microvalve is opened when negative pressure is 
applied, causing the formation of a connecting channel between the thin membrane and 
the valve seat. 
 
The material of the deflectable thin membrane is a key issue in the design of such 
microvalve. As the membrane is the only moving part in the microvalve, it should be 
flexible, durable and readily sealable against other materials (glass, silicon or other 
polymers which are used for fabricating the fluidic and pneumatic layer). The materials 
that have been used as the membrane includes silicone membrane [86], 3M tape sheet [87] 
and PDMS membrane [88, 89]. The PDMS membrane has been a good choice due to its 
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low Young’s modulus [90], excellent sealing property [91] and good biocompatibility 
[92].  However, a disadvantage is the incompatibility of PDMS with some organic 
solvents [93]. Therefore, other materials including perfluoropolyethers (PFPEs) [94] and 
commercially-available fluorinated ethylene propylene (FEP) have been introduced as 
microvalve membrane materials [83, 84]. 
 
The pneumatically actuated diaphragm microvalves have been successfully used in many 
applications. A microfluidic gradient generation and perfusion system was reported [95]. 
Microvalves were used to control 16 different inlets. A cell culture chamber can be fed by 
81 possible combinations of reagents and switching among different combination can be 
done within seconds.  
 
Li and co-workers presented a micro-mixer with a fabricated pneumatic diaphragm 
microvalve array [96]. Chambers of defined volumes were isolated by the microvalve 
array. The microdevice allowed for storing and precisely mixing aqueous solutions at 
different mixing ratios. The precision of mixing was confirmed by quantitative analysis 
of the mixing between fluorescein and deionized water. The device has potential 
applications in miniaturized diagnostic assays as well as in cell-based assays such as drug 
screening and enzyme-based biomolecule detection. 
 
The working principle of the microvalve also shows perfect analogy to metal oxide 
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semiconductor field-effect transistor (MOSFET). The membrane serves as the gate that is 
controlled by external pneumatic pressure, and the inlet and outlet work as the source and 
drain [97]. Microfluidic integrated circuits with a pressure gain of 32.0 dB [86] and 
microfluidic digital logic circuit with computing capability were demonstrated [98]. An 
advantage of microfluidic circuits is that they are immune to electromagnetic interference.  
 
A micro pump formed by serial connection of three diaphragm microvalves was also 
reported by Grover and co-workers [82]. The pumping rate of the fabricated micro pump 
ranging from 1 nl/s to over 100 nl/s was achieved. A microfluidic system for amino acid 
analysis, with parts-per-trillion limit of detection, was demonstrated by integration of a 
micro pump into the system [99].  
 
2.2.2.2 Pneumatic in-line microvalve 
The pneumatic in-line microvalve also has a three-layer structure: pneumatic layer, 
fluidic layer and bottom substrate layer. The fluidic layer is cast thin and no valve seat is 
present in the microfluidic channel, different from the pneumatic diaphragm microvalve 
[81]. The working principle of the in-line microvalve is shown in Figure 2-4. The valve is 
opened at rest (normally open). When positive pressure is applied through the control line, 
the thin fluidic layer is pushed down to the bottom substrate and the valve is closed. To 
avoid any leakage flow when the valve is closed, the shape of the fluidic channel must be 
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round instead of rectangular. Otherwise, the valve cannot be fully closed near the side 
walls of the rectangular fluidic channel. PDMS is still the commonly used material for 
fabricating such microvalves. 
 
 
Figure 2-4 Schematic illustrating the working principle of pneumatically actuated inline 
microvalve. (a) Microvalve is open at rest. (b) Microvalve is closed when positive 
pressure is applied through the pneumatic channel. The thin fluidic layer is pushed down 
to close the valve. 
 
Large-scale integration of pneumatic in-line microvalves have been successfully 
demonstrated by Quake’s group [100]. An application of this large-scale integration is in 
PCR [101]. In this work, totally 2860 microvalves were integrated on a microfluidic chip. 
400 PCR reactions were carried out simultaneously within isolated 3 nl compartments 
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formed by the microvalves. The work presented is pretty useful in biochemical 
experiments in which precious reagents are involved. 
 
Marcus and co-workers reported a microdevice for single cell mRNA isolation and 
analysis [8]. This system integrated the function of cell isolation, cell lysis, mRNA 
purification, cDNA synthesis and cDNA purification. The device was scaled up to 
process 50 different samples (50-plex) in parallel. 
 
2.3 Oligonucleotide synthesis in a microfluidic device 
Applying microfluidic technologies in oligonucleotide synthesis has been reported by 
only a few researchers. In some studies, the microfluidic device offered micro reactors for 
highly parallel synthesis [52, 102-104]. In other studies, a complete microfluidic 
synthesizer was fabricated [105, 106]. 
 
2.3.1 Microfluidic device reactor 
Oligonucleotide synthesis has been carried out in a microfluidic reactor. Hua and co-
workers developed a chemical-resistant microvalve array by coating parylene on PDMS 
[102]. The microdevice was connected to a commercial oligonucleotide synthesizer and 
the microvalve array was used to distribute the oligonucleotide synthesis reagents to 
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different reaction channels for synthesizing oligonucleotide probes. However, no 
characterization of the synthesized oligonucleotide was presented in this work. 
 
Zhou and co-workers designed a microfluidic device with around 3600 reaction chambers 
of picoliter volume [52, 103]. Oligonucleotides with different sequence were synthesized 
in individual chambers by the PGA approach. The synthesized oligonucleotide was 
successfully used for distinguishing single-base mismatch hybridization and assembly of 
gene fragment with 712 and 714 bp in length.  
 
Moorcroft and co-workers used PDMS as the solid support and directly synthesized an 
oligonucleotide within the PDMS microchannel [104]. Although PDMS has the weakness 
of incompatibility with certain organic solvents, this work proved that with substitution of 
certain organic solvents used in oligonucleotide synthesis, PDMS can still be used as a 
substrate material for oligonucleotide synthesis and potentially for fabricating DNA 
microarray. 
 
2.3.2 Microfluidic oligonucleotide synthesizer 
Oligonucleotide synthesis in microfluidic reactors was usually done by connecting a 
microfluidic device directly to a commercial oligonucleotide synthesizer. Therefore, there 
is no fluidic control within the microfluidic device. The first real microfluidic 
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oligonucleotide synthesizer was reported by Huang and co-workers [105]. In this work, 
in-line microvalves were fabricated in PFPE solvent-resistant polymer to control the flow 
of synthesis reagents. A 20-mer oligonucleotide was obtained in the device and its length 
was confirmed by gel electrophoresis.  
 
Extended research was conducted later by Lee and co-workers to simultaneously 
synthesize 16 different oligonucleotides in the microfluidic synthesizer [106]. The 
synthesized oligonucleotides were used for assembly of a gene fragment from Bacillus 
cereus of 230 bp in length without further purification. The reported microfluidic 
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ZERO DEAD-VOLUME MICROVALVE 
 
 




Microvalves integrated microfluidic devices have been used in applications where 
sequential switching of a number of reagents is needed [105, 107, 108]. In some 
applications, it is desirable to minimize intermixing and cross contamination among 
reagents as the result can be badly affected by the purity of the reagents. In traditional 
designs of microfluidic device with multiple inlets and integrated microvalves, all inlets 
are distributed along the main channel or merge into the main channel at the beginning 
(Figure 3-1). Connecting channels are usually placed in between the microvalves and the 
main channel. During operation, small volumes of reagents can be trapped within the 
connecting channels and lead to contamination of the reagent flow in the mainstream 
channel. For many applications this contamination problem is negligible. However, for 
some applications such as DNA synthesis, PCR and other analytical applications [109, 
110], it is absolutely necessary to minimize intermixing and cross contamination among 
reagents. 




Figure 3-1 Traditional design of multiple valves integrated microfluidics (a) All inlets are 
distributed along the main channel. (b) All inlets merge into the main channel at one point. 
 
A few studies have been conducted to solve the cross contamination problem [95, 111, 
112]. Braschler and co-workers have designed a virtual valve by incorporating a bypass 
channel to each inlet channel side by side [111] (as shown in Figure 3-2). When a reagent 
is selected (by increasing the corresponding inlet pressure), it flows towards the main 
channel. At the same time, the higher inlet pressure causes reagents from other inlets to 
be diverted to its bypass channel. In other words, the selected reagent washes all the other 
reagents out into their respective bypass channels. Therefore, cross contamination is 
avoided. However, due to the presence of bypass channels and absence of real valves, 
reagents keep flowing and are wasted all the time, which is not cost effective.  
 
(a)                                                               (b) 




Figure 3-2 Virtual valve designed by Braschler and co-workers. The process of switching 
from reagent B to reagent A. No cross contamination from reagent B is observed after 
fully switching to reagent A. 
 
Researchers from other groups tried to solve the cross contamination problem by adding 
adjacent purging channels to each inlet [95, 111, 112]. In such designs, the reagents left in 
the system can be washed out by the washing reagent from their corresponding purging 
channels. However, this design increases the complexity of the system and more space is 
required for placing the purging channels. 
 
In this chapter, we offer a solution for the cross contamination problem encountered in 
microfluidics. A pneumatic microvalves integrated microfluidic system with zero dead-
volume between each valving site and the main channel for minimal cross contamination 
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of reagents is demonstrated. The main channel is zigzag shaped and the microvalves sit 
exactly at each turning point of the main channel, hence creating a zero dead-volume 
between each valving site and the main channel. This zero dead-volume allows any 
reagent entering the main channel to be thoroughly washed out after use and not to 
remain entrapped within the microfluidic device. Therefore contamination of the reagent 
used in the current step to subsequently added reagents in the next step is minimized. To 
prove the zero dead-volume characteristic, PCR is used to detect trace amount of DNA 
template molecules left in the device after washing.  
 
3.2 Microvalves design and fabrication 
3.2.1 Zero dead-volume microvalve design 
The design of the zero dead-volume is shown in Figure 3-3. (NB: The term “zero dead-
volume” in this work refers to the volume between each valving site and the main 
channel is zero and hence no reagents can be trapped. However, there is always leftover 
reagent in the main channel and washing is always needed to remove these reagents from 
the main channel.) All microvalves are positioned at the turning points of a zigzag shaped 
main channel; except the outermost left valve which is used to control the main channel 
flow itself. The novel characteristic of the design is that the connecting channel between 
the main channel and each valve site, which was commonly used in previous studies [105, 
107, 108], is removed in this design. The distance between each valve site and the main 
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channel is visibly reduced to zero, hence creating a zero dead-volume between each valve 
site and the main channel. This zero dead-volume allows any reagent entering the main 
channel to be thoroughly washed out after use and not to remain entrapped within the 
microfluidic device. The zero dead-volume can effectively minimize cross contamination 
among reagents as no previous reagents can be trapped in the device. All branch channels 
are aligned with their downstream direction of the main channel to aid reagents to flow 
towards the outlet. In our design a total number of 9 valves are integrated; however, more 




Figure 3-3 Design of the microvalves integrated microfluidic device with zero dead-
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volume characteristic. The main channel is zigzag shaped. The microvalves are 
positioned at each turning point of the main channel. 
 
3.2.2 Microvalve working principles 
The working principle of the valve is shown in Figure 2-3. When positive pressure is 
applied through the pneumatic port, the membrane is pressed against the valve seat and 
the valve is closed. Liquid flow stops behind the valve seat (Figure 2-3(a)). On the other 
hand, when negative pressure is applied, the thin flexible membrane is lifted away from 
the valve seat and a connecting channel is formed between the valve seat and the 
membrane. The valve is opened and the liquid can flow over the valve seat (Figure 
2-3(b)). 
 
3.2.3 Microvalve fabrication 
3.2.3.1 Master fabrication and PDMS micromolding 
The microvalves integrated microfluidic chip was fully fabricated in PDMS (Sylgard 184 
Silicone Elastomer kit, Dow Corning, US). The chip has a fluidic-membrane-pneumatic 
three-layer structure. The fluidic layer and pneumatic layer were both fabricated by 
PDMS micromolding and the membrane was made by spin-coating PDMS on silicon 
wafer. 
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The masters for PDMS micromolding were fabricated by photolithography. SU-8 2050 
negative photoresist (Microchem, US) was applied on silicon wafers by spin-coating (~50 
µm thickness), followed by a two-step soft bake at 65 C for 3 minutes and 95 C for 6 
minutes. The resist coated wafer was then exposed to UV light at 365 nm through a 
transparency film mask, followed by a post exposure bake at 65 C for 1 minute and 95 
C for 5 minutes. The exposed photoresist was finally developed in SU-8 developer for 6 
minutes.  
 
To micromold PDMS, the fabricated master was first exposed to 1H,1H,2H,2H-
perfluorooctyl-trichlorosilane (PFOTCS) vapor under vacuum at room temperature for 15 
minutes. Fully mixed PDMS base and curing agent (10:1 ratio) was poured onto the 
master and degassed under vacuum for 30 minutes. The PDMS was then baked at 65 C 
in an oven for at least 2 hours. After baking, the PDMS microchip was peeled off from 
the master, washed with isopropyl alcohol (IPA) and double distilled water (ddH2O), 
blown dry with nitrogen and ready to use. 
 
3.2.3.2 PDMS membrane fabrication 
To fabricate the PDMS membrane, the PDMS was spin-coated on a silicon wafer. Firstly, 
2 ml of fully mixed PDMS was directly poured on the center of a 4-inch PFOTCS coated 
silicon wafer. Then the wafer was spun at 2000 rpm for 30 seconds and followed by 
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baking for 1 hour at 65 C on a hot plate. The PDMS membrane was then washed with 
IPA, ddH2O, blown dry with nitrogen and ready to use. The fabrication process of the 
PDMS membrane should be completed in a clean room environment as dust can affect 
the functionality of the fabricated PDMS membrane. 
 
The thickness of the fabricated PDMS membrane was measured by using a microscope 
(Olympus BX41). A strip of the membrane was cut out and removed from the silicon 
wafer. The cutting edge of the membrane that still stuck on the wafer was observed under 
the microscope. First, the top surface of the membrane was focused and the reading of the 
micrometer on the fine focus knob was taken. After that, the surface of the silicon wafer 
was focused by adjusting the fine focus knob and the reading was taken again. By 
calculating the difference of the two readings, the thickness of the PDMS membrane was 
obtained. 
 
Figure 3-4 shows the relationship between the thickness of the fabricated PDMS 
membrane and the spinning speed. As the spinning speed increases, the thickness of the 
PDMS membrane decreases. It is also worth to note that as the spinning speed increases, 
the rate of thickness decreasing becomes smaller. An empirical equation for the 
relationship between polymer thickness (t) and spinning speed ( ߱ ), solution 
concentration (C) and molecular weight (η) was given before: 




where K is an overall calibration constant. α, β and γ are exponential factors [113]. 
In this study, the PDMS membrane was spun at 2000 rpm and the corresponding 
thickness is 34.5±0.8 µm. 
 
 
Figure 3-4 Thickness of PDMS membranes vs. spin speed. 2 ml PDMS was applied on 
the silicon wafer. 
 
3.2.3.3 Microvalve fabrication 
The fabrication process of PDMS microvalves is shown in Figure 3-5. This process 
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membrane were treated by oxygen plasma (March Instrument Incorporated, radio 
frequency generator power 200 W, plasma treatment period 30 s, oxygen pressure 450 
mTorr) and then bonded together for 2 hours at 65 ºC. After baking, the PDMS fluidic 
layer and the thin PDMS membrane were bonded permanently. As the PDMS membrane 
was the moving part of the microvalve, it should not bond with the fluidic layer at the 
valve seat regions. Therefore, during oxygen plasma treatment, the valve seat regions on 
the fluidic layer must be covered from exposure to plasma. The valve seat was covered 
by using an oil-based permanent marker pen (Zebra, Japan) to directly mark on the target 
areas. Only oil-based marker pen instead of water-based one can be used here. This is 
because PDMS is very hydrophobic [114], as a consequence, water-based mark does not 
stick to the raw PDMS surface well and droplets can be easily formed.  
 
The bonded two-layer PDMS assembly was then peeled off from the flat silicon wafer. 
Next, the PDMS pneumatic layer and the other surface of the thin PDMS membrane were 
bonded together by treating with oxygen plasma again. Alignment of the valve seats with 
the pneumatic controlling channels was done under a stereo microscope. Finally the 
three-layer PDMS sandwich was baked at 65 ºC overnight.  To remove the valve seat 
protective marking, IPA was used to flush through the microvalves following by washing 
with ddH2O. After drying in the oven, the microchip was ready to use. 
 
 





Figure 3-5 Schematic diagram depicting the fabrication process of the microvalve (a) 
PDMS fluidic layer fabricated by micromolding and fabricated PDMS thin membrane. (b) 
Permanent bonding of fluidic layer and thin membrane by treating them with oxygen 
plasma. The valve seat is covered to avoid bonding with the thin membrane. (c) Peal off 
the fluidic layer-thin membrane complex after baking and then permanent bonding with 
pneumatic layer (fabricated also by micromolding) by treating with oxygen plasma. (d) 
The device is ready to use after baking for overnight. 
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to the thin membrane, the membrane temporarily sealed with the valve seat and the valve 
was closed (Figure 3-7(a)). Under normal conditions, i.e. without external pressure, the 
design of the valve structure would allow the microvalve to remain closed. This occurs as 
both the valve seat and the membrane are fabricated in PDMS and the reversible sealing 
of PDMS to PDMS closes the valve. However, due to the weak bonding of PDMS-PDMS 
reversible sealing, the temporary sealing can be broken by pressure of magnitude larger 
than 1 psi. Therefore, an external positive pressure is intentionally used to ensure that the 
valve is closed. In this microvalve design, dust or large particles cannot be tolerated. This 
is because that these contaminants could be stuck in between the membrane and the valve 
seat, causing the valve not to be fully closed. For this reason, in-line filters were placed in 
between the reagent reservoirs and the microchip inlets in this study to avoid malfunction 
of the microvalves. 
 
On the other hand, when a negative pressure (-4.2 psi) was applied, this negative pressure 
applied would overcome the reversible bonding and separate the membrane and the valve 
seat. The flexible membrane would be sucked towards the pneumatic channel and a 
connecting channel between the membrane and the valve seat was formed. This formed 
channel provides a fluidic path for liquid to enter the main channel (Figure 3-7(b)). After 
the valve is opened, in theory, less negative pressure is needed to maintain the open state 
of the valve. The time needed to open the valve is estimated to be less than 17 ms (liquid 
can pass through the valve when the controlling solenoid valve is energized for 25 ms to 
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allow vacuum to be applied on the membrane. However, the solenoid valve needs 8 ms to 







Figure 3-7 Photograph of the microvalve. (a) The microvalve is closed by external 
positive pressure through pneumatic channel. (b) The microvalve is opened by external 
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3.3.1.2 Leakage pressure 
The leakage pressure of the fabricated microvalve is defined as the maximum liquid 
driven pressure the valve can retain without leakage at certain valve closing pressure. 
Figure 3-8 shows the relationship between the valve closing pressure and the leakage 
pressure. As expected, the microvalve can retain higher liquid driven pressure as the 
valve closing pressure increases.  
 
From Figure 3-8, we can see that when the valve closing pressure is 0, the valve can still 
retain a pressure of ~1 psi. This is due to the weak reversible sealing of PDMS to PDMS. 
It was reported previously that the reversible PDMS-PDMS bonding can retain as much 
as 5 psi pressure [115]. In that study, both PDMS layers were thick. Therefore, the 
elasticity is negligible. However, in our case, the pressure that can be retained is much 
lower because the thin PDMS membrane is very flexible; as a consequence, a weaker 
pressure is able to bend it and causing separation of the membrane and the valve seat.  
 
The valve closing pressure used in this study is 7 psi. At this pressure, the leakage 
pressure is as high as 9.8 psi. However, the liquid driving pressure used in this study is 
only 2 psi. Therefore, under normal conditions, it can be guaranteed that there is no 
leakage of reagents through the microvalve. 
 
 





Figure 3-8 Relationship between valve closing pressure and leakage pressure of the 
fabricated microvalve 
 
3.3.2 Zero dead-volume 
The fabricated microfluidic device with integrated microvalves has zero dead-volume 
between each valving site and the main channel. As shown in Figure 3-9(a), when the 
valve controlling green reagent (green valve) was opened, the green reagent entered 
directly into the main channel and flowed toward the outlet. After switching off the green 
valve, the main channel was flushed with washing reagent which was controlled by the 
left most valve (see Figure 3-3). The green reagent can be completely flushed out of the 
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main channel, which is different from previous designs [105, 107, 108]. The complete 
removal of green liquid minimized the possibility of its contamination to following 
reagents entering the main channel. It can be seen in Figure 3-9(b) that the red reagent, 
which was controlled by an upstream valve, flowed through the main channel without 
mixing with green reagent after the green valve was closed. 
 
In the design of the microfluidic device, the main channel is zigzag shaped and 
microvalves sit exactly at each turning point of the main channel. The distance between 
each valving site and the main channel was visibly reduced to zero, hence creating a zero 
dead-volume between each valving site and the main channel. This zero dead-volume 
allowed any reagent entering the main channel to be thoroughly washed out after use and 















Figure 3-9 Photograph of the microvalve showing the zero dead-volume characteristic; 
two colored liquids (green and red) are used for illustration. (a) The microvalve that 
controls green liquid was opened. (b) The microvalve that controls green liquid was 
closed and another microvalve (located at upstream of the main channel) that controls red 
liquid was opened. No contamination of the red liquid from the green liquid was observed. 
3.3.3 Minimal cross contamination tested by PCR 
PCR was used as a detection tool to demonstrate minimal cross contamination of the zero 
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dead-volume microvalve as PCR is a very sensitive assay for detection of specific DNA 
templates. With appropriate primer design and optimized amplifying conditions, as few as 
10 DNA template molecules can be detected (Figure 3-10). 
 
PCR template (plasmid DNA, 4142 bp, Promega) with a concentration of 1×106 
molecules/µL in 1X TE buffer was controlled and fed into the main channel by one of 
these microvalves. The microvalve was opened for 5 seconds followed by TE buffer 
washing for either 10, 20 or 30 seconds. TE buffer was controlled by the left most 
microvalve. After washing for desired time, another 20 µL of the washing buffer was 
injected into the device and the effluent was collected at the outlet. The total volume of 
the PDMS main channel is 1.8 µL and flow rate is 5 µL/s. 
 
This effluent containing the DNA template molecules was mixed with other PCR 
components (PCR core system II, Promega, US) including nucleotide mix, polymerase, 
primers, buffers and water to a final volume of 50 µL and a concentration described 
previously [116]. 35 PCR amplification cycles were completed in PCR thermal cycler 
(PTC-200, MJ Research) and the product (323 bp) was analyzed by 1.5% agarose gel 
electrophoresis. The gel electrophoresis was run at 120 V for 45 minutes and stained with 
SYBR® Safe dye. (Invitrogen, US). The gel was imaged with G:BOX gel documentation 
system (Synoptics, UK).  
As shown in Figure 3-10(a), after washing with TE buffer for 10 seconds (Lane 6), the 
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effluent produced a band intensity which was stronger than that of PCR product amplified 
from 1000 template molecules (Lane 2), indicating that the amount of template molecules 
was more than 1000 in the 20 µL effluent after 10 seconds of washing. However, after 30 
seconds of washing (Lane 8), the effluent produced a band intensity which was between 
the intensity of PCR product amplified from 100 (Lane 3) and 10 (Lane 4) template 
molecules; equating to 0.5 to 5 template molecules per µL. By comparing with the 
original concentration of the PCR template stock solution (1×106 molecules/µL), there 
was a 10-6 reduction factor in the concentration. Extended washing can further reduce the 
concentration of the template molecules in the effluent.  
 
For comparison, the same experiment was conducted by microvalve system of traditional 
design as shown in Figure 3-1(a). The PCR and gel electrophoresis image is shown in 
Figure 3-10(b). It can be seen that after washing for 30 seconds, the 20 µL effluent still 
contained more than 1000 DNA template molecules, which indicates that the washing 
was not as efficient as in our design. This could lead to cross contamination of reagents 
that cannot be tolerated in certain applications. 
 
In summary, it has been demonstrated that cross contamination of reagents in our 
microdevice design can be minimized to part in a million (ppm) levels after washing for 
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In this chapter, we designed and fabricated a microvalves integrated microfluidic device 
for minimal cross contamination among the reagents. The zigzag shape of the main 
microfluidic channel and the position of each microvalve removed the dead-volume 
between the common pathway and each valving site, which effectively minimized the 
contamination of currently used reagent to subsequently added reagents. The microfluidic 
device presented in this chapter is a good candidate to be used in chemical synthesis and 
biological studies where reagents need to be added into a reaction chamber in a serial 











CHAPTER 4                               
OLIGONUCLEOTIDE SYNTHESIS 








DNA oligonucleotides are one of the most common materials used in biomolecular 
research and applications nowadays. Every year, hundreds of thousands of 
oligonucleotides are synthesized. Through the development of the phosphoramidite solid 
phase synthesis of oligonucleotide, the process has been fully automated and can be 
completed in oligonucleotide synthesizers. The oligonucleotide synthesizer has been 
commercialized for many years and there are several companies offering this product. 
However, due to the complexity of the synthesis chemistry in which a number of 
synthesis reagents are involved, those synthesizers are bulky in size. The limitation on the 
size of the commercialized oligonucleotide synthesizers makes them only suitable to be 
used in laboratory and excludes their potential in the field applications. 
 
Nowadays, due to the continuous threat from terrorism, in the field monitoring and 
detection of biological warfare and infectious disease agents such as bacteria and viruses 
become absolutely necessary. State of the art DNA based bioassays for the detection of 
these biological substances make use of oligonucleotides that function as either probes 
for hybridization or primers for PCR [117]. However, due to the lack of portability of 
existing commercialized oligonucleotide synthesizing instruments, pre-made 
oligonucleotides with known sequences need to be prepared and then brought to the 
places where bioassays are carried out. As a consequence, it is impossible to conduct 
bioassay with oligonucleotides of completely new sequences. In such case, no immediate 
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in the field detection of artificially manipulated or naturally mutated agents harmful to 
human is possible. Therefore, there is an emerging need for new instrument that can 
complement the state of the art DNA bioassay technologies by immediately synthesizing 
oligonucleotides as either primers or probes with any sequence on demand in the field. 
 
Microfluidic is a promising technology due to its small size and ease of integration. The 
invention of microfluidic valves enables microfluidic devices to manipulate and control 
fluids flow and therefore dramatically extended their use [81, 85]. Oligonucleotide 
synthesis is an application where sequential switching of a number of reagents is needed. 
Therefore, microfluidic technology is a potential solution for building a portable 
oligonucleotide synthesizer. As far as we know, a few studies have been conducted on 
developing microfluidic device for oligonucleotide synthesis [105, 106]. However, no 
work has been done aiming to develop an oligonucleotide synthesizer in a portable format 
that can be potentially used for in the field applications.  
 
In this chapter, a microfluidics based portable oligonucleotide synthesizer is proposed and 
built. The zero dead-volume microvalves integrated microfluidic chip (designed and 
reported in pervious chapter) is the core component of the portable synthesizer. By the aid 
of other peripheral components (including electronic & electrical, fluidic, and pneumatic 
part), the portable oligonucleotide synthesizer was successfully used to synthesize both 
oligonucleotide primers and probes. The sequence and biological functionality of the 
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synthesized oligonucleotide primers were analyzed and confirmed by polyacrylamide gel 
electrophoresis (PAGE) and PCR. The sequence and biofunctionality of the synthesized 
oligonucleotide probes were proven by DNA complementary and single-base mismatch 
hybridization experiments. 
 
4.2  Portable oligonucleotide synthesizer 
4.2.1 Software 
The synthesis controlling software was programmed under LabVIEW (Version 8.5, NI, 
US). The software is run on a notebook computer (VGN-P25G, SONY, Japan). Two 
screen shots of the programmed software are shown in Figure 4-1. There are two main 
interfaces in the software: the information input interface and the synthesis process 
monitoring interface.  
 
In the information input interface (Figure 4-1(a)), users are allowed to manually input the 
sequence information of an oligonucleotide to be synthesized or load it directly from a 
text format file. The direction of the sequence is from 3’ to 5’, same as the direction of the 
synthesis process. The reaction time for each synthesis step can be input in the time 
control frame. If nothing is input, the default reaction time is used. The time control 
frame is still accessible after synthesis starts. Therefore, parameters can still be changed 
when the synthesis is in progress. Figure 4-1(b) shows the synthesis monitoring interface. 
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The information about the overall synthesis progress and the current reaction in each 







Figure 4-1 Screen shots of the software for controlling oligonucleotide synthesis. The 
software was programmed under LabVIEW. (a) The information input interface (b) The 
synthesis monitoring interface. 




The PDMS microchip with integrated microvalves was operated through pneumatic ports 
by three-way normally open solenoid valves (Pneumadyne, US) that were mounted on a 
multiple-station aluminum manifold. The microvalves were closed under positive 
pressure (7 psi, relative to atmospheric pressure) and opened under negative pressure (-
4.2 psi). All reagents were driven by positive pressure (2 psi) that was controlled by two-
way normally closed solenoid valves mounted on another aluminum manifold.  
 
The positive pressure used in the system was provided by pressurized argon gas stored in 
a paintball tank (6310, Carleton Technologies Inc, US). The tank output pressure 450 psi 
was first regulated by a paintball regulator (shorty style regulator, Custom Products, US) 
to 20 psi. After that, the 20 psi pressure was further regulated down to the necessary 
pressures for closing the valve (7 psi) and driving the reagents (2 psi) by two miniaturized 
pressure regulators (Type 91, Marsh Bellofram, US). The negative pressure for opening 
the microvalves was provided by a micro-boxer pump (Cole-Parmer, US). The solenoid 
valves and vacuum pump were controlled by a 32-Channel sourcing digital output card 
(9476, NI, US) functioning as relays. The digital output card was mounted on a USB 
CompactDAQ Chassis (cDAQ-9172, NI). The electronic and electrical parts used in the 
system were all powered by 12 V DC, which was provided by two 6 V lead acid 
rechargeable batteries. 
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4.2.3 System integration 
The complete portable oligonucleotide synthesizer comprises three main parts: the 
electrical and electronic controlling part, the pneumatic controlling part, and the fluidic 
part. Figure 4-2(a) shows the schematic diagram of the portable oligonucleotide synthesis 
system. The three main parts are marked with different colors. Figure 4-2(b) shows the 
photograph of the portable oligonucleotide synthesizer.  
 
All parts forming the portable synthesizer were mounted on a home-made aluminum rack. 
The rack was divided into two main compartments. The left compartment was for 
pneumatic parts and electrical and electronic parts. The right compartment was for liquid 
reagents related parts including the microfluidic device and reagent reservoirs and waste 
bottle. The size of the aluminum rack is 42 cm × 19 cm × 28 cm and the weight is around 
6 kg. The whole rack can be inserted into an aluminum suitcase for carrying purpose. The 
portability of the whole system makes it easy to carry and suitable for being used in the 
field. A detailed list of all components used to build the portable oligonucleotide 
synthesizer can be seen in Appendix A. 
 








Figure 4-2 System design and photograph of portable oligonucleotide synthesizer (a) 
Schematic diagram illustrating the complete system, including electrical and electronic 
parts, fluidic parts and pneumatic parts. Only four microvalves are shown on the diagram 
for simplicity. (b) Photograph of the portable oligonucleotide synthesizer: (1) PC (2) 
Argon tank (3) USB-DAQ (4) Solenoid valves and manifold (5) Pressure regulators (6) 


































r (4) A (5) T
thods 
esis reage






ut of the ch
lves to olig






 4-3. The 

















































cyanoethyl)- (N,N-diisopropyl)]-phosphoramidite (dA), 5'-Dimethoxytrityl-N-benzoyl-2'-
deoxycytidine,3'-[(2-cyanoethyl)- (N,N-diisopropyl)]-phosphoramidite (dC), 5'-
Dimethoxytrityl-N-isobutyryl-2'-deoxyguanosine,3'-[(2-cyanoethyl)- (N,N-diisopropyl)]-
phosphoramidite (dG), and 5'-Dimethoxytrityl-2'-deoxythymidine,3'-[(2-cyanoethyl)- 
(N,N-diisopropyl)]-phosphoramidite (dT), were purchased from Glen Research (US). All 
reagents were directly used as received without further purification.  
 
4.3.2 Synthesis reactor 
4.3.2.1 Reactor for primer synthesis on CPG 
Oligonucleotide primer was directly synthesized on CPG. The reactor for primer 
synthesis is shown in Figure 4-4. A hole with 1 mm in diameter was punched through a 
PDMS cube. A glass microfiber filter (Schleicher & Schuell, Germany) was inserted into 
the punched hole. Two FEP tubings were then inserted into the hole from both ends. The 
glass fiber filter was thus fixed in between the two tubings. To load CPG into the reactor, 
they were first suspended in acetonitrile. Then the FEP tubing was connected to a syringe. 
The CPG (around 1 mg) was sucked into the reactor and stayed above the glass filter, 
while liquid can pass through the filter. The reactor was directly connected to the outlet of 
the microfluidic chip and ready for synthesis. 




Figure 4-4 Reactor for oligonucleotide primer synthesis. (1) PDMS cube (2) Glass fiber 
filter (3)(4) FEP tubing (5) CPG. 
 
4.3.2.2 Reactor for probe synthesis on glass slide 
Oligonucleotide probe was synthesized on a surface modified microscope glass slide. The 
synthesis reactor (Figure 4-5) was formed by reversibly sealing the glass slide with a 
PDMS microfluidic channel. The microchannel (16 mm length × 500 m width × 50 m 
height) with one inlet and one outlet was fabricated by micromolding as previously 
described (Section 3.2.3.1). The formed reactor had a volume of 0.4 L. Oligonucleotide 
probe was then synthesized on the glass slide surface within the formed channel. The 
PDMS-glass sandwich was held firmly by an acrylic case to prevent leakage. The inlet of 
the formed reactor was directly connected to the outlet of the microfluidic chip.  
 




Figure 4-5 Reactor for oligonucleotide probe synthesis. (1) Top acrylic cover with tubing 
access holes (2) PDMS microchannel (3) Surface modified microscope glass slide (4) 
Bottom acrylic case. 
 
4.3.3 Surface modification of microscope glass slides 
Oligonucleotide was synthesized on microscope glass slides as probe for DNA 
hybridization. The microscope glass slides were modified as previously reported [118]. 
They were first treated with 2% N-(3-triethoxysilylpropyl)-4-hydroxybutyramide in 95% 
ethanol for 4 hours at room temperature. After that, the slides were thoroughly rinsed 
with ethanol and then cured in vacuum oven at 120 °C for 1 hour. The treated slides were 
stored in dehumidifying cabinet if not immediately used. The scheme of the surface 
modification reaction is shown in Figure 4-6. 
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Figure 4-6 Scheme of surface modification of microscope glass slide for synthesis of 
oligonucleotide probe. 
 
4.3.4 Oligonucleotide synthesis protocol 
The phosphoramidite method was used to synthesize oligonucleotides in this study (the 
principle of synthesis chemistry can be seen in Figure 2-2). The detritylation reagent was 
substituted by 3% dichloroacetic acid in anhydrous nitromethane [119], as PDMS is 
badly swelled by dichloromethane [93]. The oxidation reagent was replaced by 0.1 M 
iodine in 9:1 pyridine/acetic acid (v/v) [104].  
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For the coupling step, there are two reagents involved. These two reagents, activator and 
phosphoramidite, can be only mixed right before the reaction. Therefore, these two 
reagents were injected into the microfluidic chip in an alternating fashion for a number of 
times. This injection manner can improve the mixing of these two reagents in the 
microfluidic chip, which is important for achieving high coupling efficiency. The 
reagents and reaction time for each step are summarized in Table 4-1. The total time for 
one synthesis cycle (adding one nucleotide) is 9 minutes. 
 
Table 4-1 Reagents and reaction time for oligonucleotide synthesis 
No. Reaction Reagent 
Time 
(minutes) 
1 Detritylation 3% dichloroacetic acid in nitromethane 1.5 
2 Washing Acetonitrile 1 
3 Coupling 
0.45 M tetrazole in acetonitrile  
0.1 M phosphoramidite in acetonitrile (dA, dT, 
dG or dC) 
3 
4 Washing Acetonitrile 1 
5 Oxidation 0.1 M iodine in 9:1 pyridine/acetic acid (v/v) 1.5 
6 Washing Acetonitrile 1 
 
4.3.5 PAGE and PCR 
Oligonucleotide synthesized on universal CPG was used as primer for PCR. 15% PAGE 
was used to confirm the length of the synthesized oligonucleotide. The ratio of 
acrylamide and bis-acrylamide is 29:1 (Bio-rad, US). The prepared gel was pre-run in 1X 
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TBE buffer for 30 minutes at 200 V. The samples were heated to 95 °C for 2 minutes, 
then immediately chilled by transferring onto ice. After that, the samples were added into 
the wells and the electrophoresis was run for 1.5 hours at 200 V. Then the gel was stained 
with SYBR® Gold dye and imaged with a G:BOX gel documentation system (Synoptics, 
UK). 
 
The synthesized oligonucleotide was used as reverse primer to amplify E. coli 16S 
ribosomal RNA. The 596 bp PCR product was run in 1.7% agarose gel for 45 minutes at 
120 V. The gel was also imaged with the G:BOX gel documentation system. 
 
4.3.6 Probe deprotection and hybridization 
Oligonucleotide probe was synthesized on a surface modified glass slide for hybridization. 
After synthesis, the slide was treated with ethylenediamine:ethanol (1:1) for 2 hours at 
room temperature to remove the protecting groups. It was then washed thoroughly with 
ethanol followed by ddH2O and finally blown dry with nitrogen. 
 
For hybridization, 5 M Texas Red labeled oligonucleotide was dissolved in 0.5X SSC 
buffer containing 0.1% SDS. 15 L of the fluorescence labeled oligonucleotide was 
spotted on the glass slide and then covered with cover slide. The hybridization was taken 
place at 40 °C for 2 hours. After that, the glass slide was washed with 1X SSC buffer and 
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0.5X SSC buffer at 37 °C. The glass slide was then blown dry with compressed nitrogen. 
The fluorescence image was taken by using a CCD color digital camera, Retiga 4000R 
(QImaging), connected to a system microscope (Olympus BX41) with a mercury arc 
(Olympus HBO103W/2) excitation source. 
 
4.4 Result and discussion 
4.4.1 PCR primer synthesis 
To demonstrate whether oligonucleotide could be synthesized by the portable 
oligonucleotide synthesis system and used as a primer for PCR, a 16-mer oligonucleotide 
(sequence 5’-GGTTGCGCTCGTTGCG-3’) was synthesized on universal CPG. The 
synthesized oligonucleotide was then cleaved from CPG by concentrated ammonium 
hydroxide (28% in water) at 65 °C overnight. The synthesized oligonucleotide was used 
as the reverse primer for amplifying E. coli 16S ribosomal RNA.  
 
The oligonucleotide synthesized in the portable synthesizer was analyzed by PAGE. 
Figure 4-7 shows the PAGE image of the synthesized oligonucleotide. From the PAGE 
image, it can be seen that main product of the synthesized oligonucleotide is the 16-mer 
full length oligonucleotide (lane 3), which has the same mobility as comparing with the 
HPLC purified commercial oligonucleotide of the same sequence (lane 2). The main 
impurity in the product is n-1 mer. By measuring the band intensity, the final yield of the 
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full length product was about 70%, corresponding to a step wise yield of 98%. This yield 
was satisfactory and comparable with synthesis yield reported before [105]. The 




Figure 4-7 PAGE image for synthesized oligonucleotide length confirmation. Lane 1: 
oligonucleotide ladder. Lane 2: HPLC purified commercial oligonucleotide with the same 
sequence. Lane 3: oligonucleotide synthesized by the portable oligonucleotide synthesizer. 
 
The synthesized 16-mer oligonucleotide was then used as reverse primer in PCR to 
amplify E. coli 16S ribosomal RNA. The agarose gel electrophoresis image of the 596 bp 
PCR product is shown in Figure 4-8. The sequence of the forward primer was 5’-
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CCAGCAGCCGCGGTAA-3’. Lane 2 shows the positive control with both primers 
purchased. For lane 3, the reverse primer was synthesized by the portable synthesizer. 
The gel electrophoresis image shows that the target DNA template was successfully 
amplified when using the oligonucleotide synthesized in our synthesizer as the reverse 
primer. Therefore, the sequence and biological functionality of the synthesized 
oligonucleotide was successfully demonstrated. 
 
 
Figure 4-8 The gel electrophoresis image of PCR product. Lane 1: 50bp DNA ladder. 
Lane 2: positive control with both forward and reverse primer purchased. Lane 3: PCR 
product amplified by the synthesized oligonucleotide in our portable synthesizer as 
reverse primer. 
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4.4.2 Probe synthesis 
4.4.2.1 Probe for oligonucleotide hybridization 
To further test the function of the portable oligonucleotide synthesizer, an oligonucleotide 
probe (5’-GGTTGCGCTCGTTGCG-3’) was synthesized on surface modified glass slide. 
After synthesis, the probe was hybridized with a complementary DNA which is labeled 
with 6-carboxyfluorescein (6-FAM) fluorophore (5’-CGCAACGAGCGCAACC[6-
FAM]-3’). The fluorescence image was taken by using fluorescence microscope. The 
fluorescence image in Figure 4-9 shows that the complementary DNA was successfully 
hybridized to the synthesized oligonucleotide probe, which also confirmed the sequence 
and biofunctionality of the synthesized oligonucleotide. 
 
 
Figure 4-9 Fluorescence image of 6-FAM labeled complementary DNA hybridized to 
synthesized probe 
500 m 
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4.4.2.2 Probe for single-base mismatch differentiation 
Probes were also synthesized for single-base mismatch differentiation in order to confirm 
the function of the portable oligonucleotide synthesizer. The sequence of the synthesized 
probe on the modified slide was 5’-GCTACAACTGCTTATG-3’. The complementary 
oligonucleotide for hybridization with Texas Red labeled at the 3’ end (5’-
CATAAGCAGTTGTAGC[TxRd]-3’) was purchased. For comparison, a probe with 
single-base mismatch was also synthesized. The sequence of oligonucleotide with single-
base mismatch was 5’-GCT ACC ACT GCT TAT G-3’.  
 
The fluorescence image in Figure 4-10(a) shows that the dye labeled complementary 
strand successfully hybridized with the probe synthesized on the glass slide. Figure 
4-10(b) shows the fluorescence image of the hybridization to the probe with single-base 
mismatch. From the images, it can be observed that the fluorescence intensity of the 
complementary hybridization is much higher than that of hybridization with single-base 
mismatch (the ratio of the fluorescence intensity is about 8 by measuring with ImageJ 
software), indicating the higher hybridization efficiency between complementary 
sequences. Therefore, the sequence and biological functionality of the oligonucleotide 












Figure 4-10 Fluorescence image of the synthesized probe hybridizing with Texas Red 
labeled oligonucleotide. (a) Complementary sequence. (b) Single-base mismatch. 
500 m 
500 m 




In this chapter, we presented a microfluidic device based portable oligonucleotide 
synthesizer. To the best of our knowledge, this is the first portable oligonucleotide 
synthesizer reported. The core component of the portable synthesizer is the zero dead-
volume microvalves integrated microfluidic chip which was designed in the previous 
chapter. The portable oligonucleotide synthesizer was successfully used to synthesize 
oligonucleotide primers. The length of the synthesized primer was confirmed by PAGE. 
The primer was successfully used to amplify bacteria ribosomal RNA gene, therefore 
proving the sequence and biofunctionality of the synthesized primer. Oligonucleotide 
probe was also successfully synthesized on a flat glass surface by the portable synthesizer. 
The sequence and biological functionality of the synthesized oligonucleotide probes were 
demonstrated by DNA complementary and single-base mismatch hybridization 
experiments. The time for synthesizing one base is 9 minutes and therefore 3 hours is 
needed for a oligonucleotide with typical length of 20mer. The portable synthesizer 
reported here has the potential capability of synthesizing oligonucleotide of any sequence 











CHAPTER 5                                            
PORTABLE GENERIC DNA 
HYBRIDIZATION BIOASSAY SYSTEM 
 
 




Bioassay based on DNA hybridization has been developed for many years for different 
applications such as detection of organism and diagnosis of diseases [120, 121]. When 
conducting these bioassays, the DNA targets are usually labeled with fluorescent 
molecules for detection purpose. Therefore, it is important to accurately measure the 
fluorescence signal in such bioassays. 
 
As stated previously, state of the art DNA based bioassays for the detection of biological 
warfare and infectious disease agents such as bacteria and viruses make use of pre-made 
oligonucleotides that function as either probe or primer [117]. In the previous chapter, we 
have developed a portable oligonucleotide synthesizer based on microfluidic technology. 
The portable synthesizer has the potential to synthesize oligonucleotide of any sequence, 
thus complementing state of the art DNA based technologies for in the field application. 
However, to detect the result of DNA based bioassays in the field, for example DNA 
hybridization, the detection system must also be fabricated in a low cost and portable 
format. 
 
In many systems, expensive laser excitation source and sophisticated detector are used, 
which make them not suitable for in the field applications [122]. There are several studies 
using cheaper light sources or simple photo detectors such as light emitting diode (LED) 
and photodiode [123-125]. However, some studies focused on fluorescence detection in 
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liquid phase instead of solid phase [123, 124]. In the other studies, DNA probes were  
directly immobilized on the photodiode surface, limiting the reusability of the detector 
[125]. 
 
In this chapter, we present the first portable generic DNA hybridization based bioassay 
system. The system integrates the portable oligonucleotide synthesizer presented in the 
previous chapter and a Texas Red fluorescence detection system based on a LED and 
photodiode. The fluorescence detection system can detect Texas Red fluorophore as low 
as 0.5 fmol and was successfully used for differentiating complementary and single-base 
mismatch hybridization. The complete generic portable bioassay system was successfully 
used to distinguish DNA from two different bacteria strains. The portable system has the 
potential to detect any DNA sequence in the field. 
 
5.2  System design 
5.2.1 Texas Red fluorescence detection system 
Figure 5-1(a) shows the schematic of the Texas Red fluorescence detection system. A 
white color Luxeon Emitters (LXHL-PW01, Lumileds Lighting, US) was used as the 
light source for excitation light. The LED was powered by a constant current Stardrive 
LED driver (1 Watt, Sumatec Ltd, UK). The white light was first collimated by a lens 
(f=30 mm, Edmund Optics, US) and then passed through an excitation filter (HQ575/50x, 
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Chroma, US). The filtered light was reflected by a beam splitter (Z594/750rpc, Chroma, 
US) and focused onto the sample. The fluorescence emitted from the sample passed 
through the emission filter (HQ645/70m-2p, Chroma, US) and was focused by a lens on a 
high sensitivity, low noise photodiode detector with built-in pre-amplifier. (S8745-01, 
Hamamatsu photonics, Japan). The photodiode was powered with ±6 V and the signal 
from the pre-amplifier was directly measured with an NI 9219 Analog Input card 
(National Instrument, US) without further amplification. All optical parts were fixed into 
a home-made light tight aluminum housing. The photograph of the detection system is 
shown in Figure 5-1(b). Spectrum of the various optical parts including LED, excitation 
and emission filters, beam splitter, and photodiode can be seen in Appendix C. 
 
5.2.2 Integration of fluorescence detection and oligonucleotide synthesis system 
To build the portable generic DNA bioassay instrument, the fluorescence detection 
system was further integrated into the portable oligonucleotide synthesizer developed in 
previous chapter. As on-the-chip DNA hybridization is required, the microvalve 
integrated microfluidic chip and the oligonucleotide probe synthesis reactor (as shown 
previously in Figure 4-5) were both redesigned to incorporate the new function, as 
described in the following. 
 







Figure 5-1 (a) Schematic diagram of the Texas Red fluorescence detection system (b) 
Photograph of the Texas Red fluorescence detection system. 
 
5.2.2.1 Modified microfluidic chip 
The microfluidic chip used in the portable oligonucleotide synthesizer has totally 9 
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modified to realize the on-site DNA hybridization. Comparing with the previous reactor, 
the current one has two more elements, the temperature sensing and the heating parts.  
 
The temperature sensor (PT100, RS) was sandwiched in between the top acrylic cover 
and the microscopy glass slide on which the probe is synthesized (part 3 in Figure 5-3). 
Thus the temperature measured is at the top surface of the glass slide and it is also the 
surface on which the hybridization occurs. Therefore, the temperature measured is much 
more accurate than placing the sensor elsewhere. 
 
The heating unit was placed under the bottom acrylic case. A heater mat was placed on 
the bottom surface of an aluminum piece (part 6 in Figure 5-3). The aluminum piece 
directly contacted with the synthesis glass slide. Heat can be evenly distributed over the 
aluminum piece, which can guarantee the uniform heating of the glass slide and increase 
the temperature controlling accuracy. A hole was drilled into the aluminum piece to allow 
excitation and emission light to pass through for fluorescence detection. 
 





Figure 5-3 Design of oligonucleotide probe synthesis and hybridization reactor. (1) Top 
acrylic cover with tubing access hole (2) PDMS microchannel (3) PT100 temperature 
sensor (4) Surface modified glass slide (5) Bottom acrylic case (6) Heating unit with light 
access hole. The whole assembly was held together by screw and then fixed inside the 
fluorescence detection box. 
 
5.2.2.3 Portable DNA bioassay system 
The photograph of the complete portable generic DNA bioassay system is shown in 
Figure 5-4. The fluorescence detection system was fixed inside the right partition 
chamber of the original portable oligonucleotide synthesizer. The probe synthesis and 
hybridization reactor was fixed on the upper wall inside the fluorescence detection device 
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microfluidic chip by FEP tubing. After probe synthesis, the hybridization reagent can be 
manually injected into the reactor using a syringe through the port which was extended 
outside the aluminum rack (see part 13, this injection port was controlled by valve 10 on 





Figure 5-4 Photograph of the portable system: (1) PC with control software (2) Argon 
tank (3) NI-DAQ (4) Solenoid valves and manifold (5) Pressure regulators (6) Vacuum 
pump (7) Batteries (8) Microfluidic chip (9) Synthesis and hybridization reactor (10) 
LED (11) Photodiode (12) Lenses, filters and beam splitter (13) Injection port for 
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5.3 Materials and methods 
5.3.1 Hybridization probe immobilization on glass slide 
Hybridization probes were immobilized on glass slide for testing the function of 
fluorescence detection unit. The glass slide was first cleaned with piranha solution 
(sulfuric acid : hydrogen peroxide, 7:3) at 120 ºC for 30 minutes followed by thoroughly 
washing with ddH2O. The cleaned glass slide reacted with 2% 3-
aminopropyltriethoxysilane (APTES) in acetone at room temperature for 2 hours and was 
then baked in vacuum oven at 120 ºC for 1 hour. The glass surface was bearing amine 
groups now. After that, 20 L of 50 mM disuccinimidyl suberate (DSS) in 
dimethylformamide (DMF) was spotted on the amine functionalized glass slide and 
covered with cover slide for 1 hour at room temperature. After washing with acetone, 
1L of amine labeled oligonucleotide probe (10 M in 50 mM phosphate buffer pH 7.4) 
was spotted on the activated surface for 2 hours. After washing, the slide was ready to use 
for hybridization. 
 
5.3.2 Asymmetric PCR 
For bacteria strains differentiation, the bacteria genomic DNA (Bacillus cereus ATCC 
14579 and Salmonella enterica subsp. enterica ATTC 13311) was first amplified by 
asymmetric PCR. One primer is labeled with Texas Red fluorophore, thus the PCR 
product containes the fluorophore for hybridization detection. The ratio of Texas Red 
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labeled primer and non-labeled primer was 10:1. Therefore, more fluorescence labeled 
single-strand target DNA can be produced for hybridization and the competition between 
the hybridization probe and the target-complementary strand can be reduced.  
 
5.3.3 DNA hybridization 
The hybridization of the Texas Red labeled PCR product to in situ synthesized probes 
took place at 45 C for 1 hour in 5X SSC buffer containing 0.1% SDS. The temperature 
was controlled by the integrated hybridization reactor. After hybridization, washing was 
carried out with 0.1X SSC at 37 C for 5 minutes twice. 
 
5.4 Result and discussion 
5.4.1 Fluorescence detection system 
5.4.1.1 System characterization 
To characterize the Texas Red fluorescence detection system, a serial dilution of Texas 
Red labeled oligonucleotide in water ranging from 1 nM to 500 nM was prepared. Then 
0.5 μL of each dilution was spotted on glass slide (corresponding to 0.5 fmol to 250 fmol). 
As the size of the spot was smaller than the size of the excitation light spot, all 
fluorophores can be excited.  
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Texas Red fluorophore was chosen as the detection target because of the following three 
reasons. Firstly, Texas Red is one of the most commonly used fluorophore for labeling 
DNA. Secondly, the peak wavelength intensity of the excitation light source (LED) 
matches with Texas Red’s peak excitation wavelength (589 nm). Thirdly, at the peak 
emission wavelength of Texas Red (615 nm), the photo sensitivity of the photodiode is 
higher (comparing with its sensitivity at peak emission wavelength of 6-FAM 520 nm) 
(refer to Appendix C).  
 
Figure 5-5 shows calibration curve of the Texas Red detection system. It can be seen that 
the detection system can detect Texas Red fluorophores ranging from 0.5 fmol to 150 
fmol with good linearity (R2=0.989). The system is saturated when the amount of 
fluorophore is above 200 fmol. It is worth noting that at the lower range (0.5 fmol to 12.5 
fmol), the linearity of the detection system is even better (R2=0.996) and this range is 
coincident with the amount of fluorophores from DNA hybridization observed in this 
study (shown in the following).  
 




Figure 5-5 Calibration curve for Texas Red fluorescence detection system. The lower 
range of the calibration curve (corresponding to amount of Texas Red fluorophore from 
0.5 fmol to 12.5 fmol) is enlarged. 
 
It was reported that the density of DNA probe immobilized on commercial ammine-
reactive glass slides was above 1012 probes/cm2 [126], corresponding to 1.66 ×10-5 
fmol/µm2. Thus, by assuming 100% hybridization efficiency, our system can detect 
hybridization to such probe surface with diameter as small as 200 µm. 
 
5.4.1.2 Detection of complementary and single-base mismatch DNA hybridization 
The fluorescence detection system was then tested by DNA hybridization to a surface 
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immobilized probe. Two amine labeled oligonucleotide probes (5’-
GCTACAACTGCTTATG[Amine]-3’ and 5’-GCTACCACTGCTTATG[Amine]-3’) were 
immobilized on modified glass slide through DSS linker as described. These two 
oligonucleotides have one base difference in the middle of the sequence. A Texas Red 
labeled oligonucleotide (5’-CATAAGCAGTTGTAGC[TxRd]-3’), complementary to the 
first oligonucleotide but with single-base mismatch to the second, was then hybridized to 
both immobilized probes. After proper washing, the hybridization was measured by the 
fluorescence detection system. 
 
From the result of our system, the signal for complementary hybridization was 0.190 V. 
However, the signal for single-base mismatch was just 0.018 V. The ratio of these two 
signals is as large as 10.6, indicating that the fluorescence detection system successfully 
discriminate the fluorescence signal from complementary and single-base mismatch 
hybridization. A point to note is that both signals fall in the range where the system has 
higher linearity.  
 
For comparison, the fluorescence images of the complementary and single-base mismatch 
hybridization were also taken by our fluorescent microscope system (Qimaging CCD 
camera Retiga 4000R, and Olympus BX41 microscope) (Figure 5-6). The fluorescence 
intensity was measured by using ImageJ software. The ratio of the fluorescence intensity 
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was used to amplify 16S rRNA of the two strains (5’-CCTACGGGAGGCAGCAGT-3’ 
and 5’-[TxRd]CGTTTACGGCGTGGACTAC-3’). The reverse primer was labeled with 
Texas Red at 5’ end to generate the fluorescence signal for detection. Two probes 
(Bacillus 5’-CGCGCAGGTGGTTTCTTAA-3’ and Salmonella 5’-
GGTCTGTCAAGTCGGATGTG-3’), each is specific to one strain, were synthesized on 
surface modified glass slides. The synthesis process was same as reported in previous 
chapter. Each probe was then hybridized with both Texas Red labeled PCR product and 
the hybridization results were examined by the fluorescence detection system. 
 
As shown in Figure 5-7, Texas Red labeled PCR products from two different bacteria 
strains hybridized only to the synthesized probe that is specific to its strain. The 
fluorescence signals from specific hybridization were much stronger than that from cross-
hybridization. Therefore, these two bacteria strains were successfully differentiated by 
our portable generic bioassay instrument.  
 




Figure 5-7 3D bar graph showing the fluorescence signal from specific and cross 
hybridization between PCR products of two different bacteria strains and synthesized 
strain specific probes. 
 
It can also been seen that the fluorescence signals from specific hybridization were not as 
high as that from previous hybridization between oligonucleotide and oligonucleotide 
(5.4.1.2). This could be due to the fact that the PCR product has a length of 475-mer. The 
hybridization efficiency can be affected by the length of the hybridization target [127].  
Longer PCR product can lower the hybridization efficiency, leading to smaller 
fluorescence signals. However, the signals are still within the detection range where the 
system has higher linearity. 
 
  




In this chapter, we have developed a portable and generic DNA bioassay instrument. To 
the best of our knowledge, this is the first portable system developed for in situ synthesis 
of oligonucleotide probe and integrated detection of DNA hybridization. The portable 
oligonucleotide synthesizer is capable of synthesizing probe of any sequence on demand. 
The Texas Red fluorescence detection device, based on a LED excitation light source and 
a photodiode detector, can detect Texas Red fluorophore of the amount down to 0.5 fmol 
and is able to discriminate complementary and single-base mismatch DNA hybridization. 
The complete system was successfully used to distinguish different bacteria strains by 
synthesizing strain specific probes and detecting the hybridization signals within the 
portable instrument. The system presented in this work has the potential to detect any 
DNA sequence in the field. We envisage that our system could help to enable fast 
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6.1 Conclusion and original contributions 
This work focused on the development of a portable oligonucleotide synthesizer and 
generic DNA hybridization based bioassay instrument due to the emerging need of in the 
field synthesis of DNA oligonucleotide and in situ detection of specific DNA sequence. 
In the following paragraphs, the important findings that were obtained in this work are 
outlined. 
 
The first part of this study was concerned with designing a microvalves integrated 
microfluidic chip. The distinct advantage of the developed microchip is that it has a zero 
dead-volume characteristic. This property is attributed to the special design of the zigzag 
shaped main channel and the microvalves were located exactly at each turning point of 
the zigzag shaped main channel. This design removed the connecting channels which are 
found in previous designs. The absence of the connecting channels eliminated the 
possibility of liquid reagents trapped within the microdevice, which could lead to cross 
contamination to subsequently added reagents. The zero dead-volume characteristic of 
the microdevice was proven by using PCR to detect trace amount of DNA template 
molecules left in the device after washing. The result showed that cross contamination of 
reagents in our microdevice design can be minimized to ppm levels after 30 seconds 
washing, which is more efficient when comparing with traditional design. We believe that 
the microdevice developed here is extremely useful for applications in which cross 
contamination is a critical issue and lead to unpredictable results. DNA oligonucleotide 
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synthesis is such an application in which cross contamination among reagents makes 
successful synthesis of oligonucleotides problematic. 
 
The second part of this work concentrated on developing a portable oligonucleotide 
synthesizer with the zero dead-volume microfluidic device that was obtained in the first 
part of this work as the core component. The portable synthesizer consists of three main 
parts: electronic & electrical part, pneumatic part and fluidic part. The synthesis 
controlling software was developed with LabVIEW to control and monitor the whole 
synthesis process. All components forming the portable synthesizer were fixed within a 
home-made aluminum rack. The rack had a dimension of 42 cm × 19 cm × 28 cm and 6 
kg of weight and can be inserted into a suitcase for ease of carrying. The function of the 
portable oligonucleotide synthesizer was proven by synthesizing both oligonucleotide 
primers and probes. The primers synthesized were analyzed by PAGE to confirm the 
length. The sequence and biological functionality of the synthesized primers were 
successfully demonstrated by amplifying E.coli 16S ribosomal RNA. The synthesized 
probes were successfully used for DNA hybridization and had the ability to differentiate 
complementary and single-base mismatch sequence, which further confirmed the 
sequence and biological functionality of the synthesized probes. In summary, the 
developed portable synthesizer is capable of synthesizing an oligonucleotide with any 
sequence on demand as either primer or probe. As far as we know, this is the first portable 
oligonucleotide synthesizer reported. 
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The third part of this work was concerned with developing a portable generic DNA 
hybridization based bioassay system. A fluorescence detection unit was designed and 
integrated into the portable synthesizer to form the generic bioassay system. The 
fluorescence detection unit, using an ultra bright LED as the excitation source and a high-
sensitivity photodiode as the detector, was capable of detecting Texas Red fluorophore of 
amounts ranging from 0.5 fmol to 150 fmol.  The detection unit had a good linearity at 
this range of Texas Red fluorophore amount and even a better linearity at the lower range, 
which was also coincident with the amount of fluorophores from DNA hybridization 
experiments. The Complementary and single-base mismatch hybridization were easily 
discriminated by using the fluorescence detection unit. The complete bioassay system, 
formed by integrating the portable oligonucleotide synthesizer and the fluorescence 
detection system, was successfully used to differentiate two bacteria strains by in situ 
synthesis of strain specific probes, hybridization to Texas Red labeled amplicons and then 
on site detection of the fluorescence signals. To the best of our knowledge, no such 
generic and portable DNA hybridization bioassay system was reported previously. As the 
system has the potential to detect DNA target of any sequence for in the field applications, 
we envisage that our system could help to enable fast responses to emerging bio-threats 
for homeland security and in pandemics.  
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6.2 Technical challenges 
PDMS is one of the widely used polymeric materials for fabrication of microfluidic 
device. However, it can be badly swelled by organic solvent used in oligonucleotide 
synthesis such as dichloromethane in detritylation reaction and tetrahydrofuran in 
oxidation reaction. To overcome this problem, these traditionally used reagents were 
replaced. For detritylation reaction, dichloroacetic acid was dissolve in nitromethane, 
which does not swell PDMS, instead of dichloromethane. For oxidation reaction, iodine 
was dissolved in pyridine/acetic acid mixture instead of THF/Pyridine/H2O mixture. The 
replace of traditional oligonucleotide synthesis reagents does not affect the synthesis 
yield as the step wise yield is 98%, which is comparable to yield reported before [105]. 
 
In building the portable oligonucleotide synthesizer, the size of each component is critical. 
As microvalve and liquid reagents are both controlled by argon gas pressure, a gas tank 
must be integrated into the system. However, the pressurized gas tank used in laboratory 
is too big and too heavy to integrate into the portable system. We finally adapted the gas 
tank which is used in paintball game into our portable system. The Output pressure from 
the paintball tank (~450 psi) is first regulated to 20 psi by a paintball tank regulator and 
then regulated to pressures needed in the portable system. The use of paintball tank in the 
system dramatically reduces the size and weight of the complete system.  
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6.3 Future works 
In the present work, single oligonucleotide was synthesized at one time in current system 
design. However, the system can be easily extended due to the flexibility of the system 
design and modular configuration of electronic and pneumatic hardware. One future work 
could be simultaneously synthesizing multiple oligonucleotides within the portable 
oligonucleotide synthesizer, which can significantly improve the throughput of the 
portable system.  
 
This task could be done by designing a new synthesis reactor in which microvalves are 
integrated. The microvalves within the synthesis reactor can be used to selectively deliver 
synthesis reagents to certain reaction chambers (especially different phosphoramidite 
monomers during coupling reaction. All other reactions are universal regardless of the 
sequence to be synthesized, thus no selective delivery of reagents is required). The 
coupling reactor will occur in the chambers where coupling reagents are delivered. 
Therefore, multiple oligonucleotides with different sequence could be obtained by the 
proposed new reactor.  
 
Another possible way to simultaneously synthesize multiple oligonucleotides, especially 
for oligonucleotide probe, is to adopt a photochemical synthesis approach (reviewed in 
2.1.2.3). A selective light excitation unit, such as an addressable LED array, could be 
designed and incorporated into the system. The excitation unit could selectively activate 
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certain regions on the flat solid support surface to remove the 5’-OH protecting group. 
The surface area with proper activation could then couple with the incoming 
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Appendix A List of Components for the Portable System 
 
 No. Component QTY Company Product No. / Model Remark 
Oligonucleotide 
Synthesizer 
1 Computer * 1 Sony VGN-P25G  
2 Paintball Tank 1 Carleton 6310-47416 Store argon gas 
3 Tank on/off Valve 1 Custom Products Mini ASA Adapter Tank main valve 
4 Grip Paintball Regulator 1 Custom Products Short Black 2000 psi to 20 psi 
5 Macroline Hose Kit 1 -------------- --------------  
6 CompactDAQ Chassis * 1 NI NI cDAQ-9172  
7 Sourcing Digital Output * 1 NI NI 9476 Function as relay 
8 Low Pressure Regulator 1 1 Marsh Bellofram 962-036-000 Fluids driven pressure 
9 Low Pressure Regulator 2 1 Marsh Bellofram 962-083-000 Valve control pressure 
10 Manifold 10 Stations 2 Pneumadyne MSV10-10  
11 Solenoid Valve 2 Way 9 Pneumadyne S10MM-20-12-3 Normally Close 
12 Solenoid Valve 3 Way 10 Pneumadyne S10MM-31-12-3 Normally Open 
13 6V Battery * 2 Powerfit NAS30601D2VW0SC  
14 Micro-Boxer Pumps 1 Cole-Parmer EW-79600-16 Vacuum to open valve 
15 Inline Filter 10 Upchurch A-425 Fluids filter 
16 FEP Tubing 1 Cole-Parmer 06406-60 Fluids tubing 
17 Polyurethane Tubing 1 Pisco UB 0640-20B Pneumatic tubing 
18 Polyurethane Tubing 1 Pisco UB 1810-20B Pneumatic tubing 
19 Tube Fitting 19 Pisco PC 180-M5M Fittings for 18 & 10 
20 Tube Fitting 1 Pisco PY 6M Fittings for 17 
21 Tube Fitting 2 Pisco PLJ 6M Fittings for 17 
22 Tube Fitting 1 SMC KJS01-32  
23 HPA Fill Station 1 PMI CGA 580 Argon tank fill station 
24 Aluminum Suitcase 1 RIMOWA  Carrying case 
25 Aluminum Rack 1 Home-made  Mounting 
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26  Switches, cables, others various   Electronic accessories 
27 PDMS microvalve chip 1 Self-fabricated  Microfluidic valves 




29 Universal Analog Input 1 NI NI 9219 Measure signal from 
photodiode and PT 100 
30 LED 1 Lumileds  LXHL-PW01 White, 1W 
31 Stardrive LED driver 1 Sumatec 1W Constant current source 
32 Lense 3 Edmund Optics 47343  
33 Excitation Filter 1 Chroma HQ575/50x  
34 Emission Filter 1 Chroma HQ645/70m-2p  
35 Beam Splitter 1 Chroma Z594/750rpc  
36 Photodiode 1 Hamamatsu  S8745-01 Built-in pre-amplifier 
37 Filter cube 1 Olympus UMF-2 Mounting 
38 PT100 Temp Sensor 1 RS 362-9834 For hybridization 
39 Heater Mat 1 RS 245-499 For hybridization 
40 Aluminum Housing 1 Home-made  Housing 




Appendix B Assignment of NI 9476
Channel Connection Control String Remark 
DO0 A1 3 Washing DO1 B1 
DO2 A2 12 Monomer A DO3 B2 
DO4 A3 48 Monomer T DO5 B3 
DO6 A4 192 Activator DO7 B4 
DO8 A5 768 Monomer G DO9 B5 
DO10 A6 3072 Monomer C DO11 B6 
DO12 A7 12288 Detritylation DO13 B7 
DO14 A8 49152 Oxidation DO15 B8 
DO16 A9 196608 Argon DO17 B9 
DO18 A10 262144 Hybridization
DO19~30 NOT USED  
DO28 Heater 805306368 ----- DO29 
DO30 LED 1073741824 ----- 
DO31 Pump 2147483648 Vacuum
Remarks: A1 is solenoid valve 1 mounted on aluminum manifold A to control the operation of microfluidic valve; B1 is solenoid valve 1 mounted on 
aluminum manifold B to drive oligonucleotide synthesis reagent; Heater is connected to both DO28 and DO 29 as working current of the heater is larger 
than the maximum current allowable in a single channel. 
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